Ghosh A C, Bora M M, Dutta N N
Chemical Engineering Division, Regional Research Laboratory, Jorhat, India.
Bioseparation. 1996 Apr;6(2):91-105.
This paper presents an overview on the developments in liquid membrane separation and purification of commercially important beta-lactam antibiotics. Reactive extraction via liquid-liquid ion exchange or ion-pair extraction mechanism can be exploited to develop liquid membrane processes for separation and concentration of penicillins and cephalosporins. Because of high selectivity and flux, liquid membrane processes can be adopted for direct extraction of beta-lactams from fermentation broth. Other advantages of liquid membrane technologies are low capital and operating costs, compact unit installation in commercial plants, low material inventory, etc. Both emulsion liquid membrane and supported liquid membrane techniques can be effective under the reactive extraction conditions. However, the stability problems of liquid membrane should be resolved before commercial application can be established. Alternately, reactive extraction in non-dispersive mode with hollow fiber membranes can be an attractive and viable strategy for practical application. Applicability of the liquid membrane processes has been discussed from process engineering and design considerations.
本文概述了液膜分离和纯化具有商业重要性的β-内酰胺抗生素的进展。可利用液-液离子交换或离子对萃取机制的反应萃取来开发用于分离和浓缩青霉素和头孢菌素的液膜工艺。由于具有高选择性和通量,液膜工艺可用于从发酵液中直接萃取β-内酰胺。液膜技术的其他优点包括资本和运营成本低、在商业工厂中装置紧凑、物料存量低等。在反应萃取条件下,乳化液膜和支撑液膜技术都可能有效。然而,在建立商业应用之前,液膜的稳定性问题应得到解决。另外,采用中空纤维膜的非分散模式反应萃取可能是一种有吸引力且可行的实际应用策略。已从工艺工程和设计考虑方面讨论了液膜工艺的适用性。